Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Kidney International|May 2, 2024
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIVAnnegret Pelchen-Matthews, Amanda Mocroft, Lene Ryom, et al.
Cell|August 26, 2017
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer PatientAlejandro Jiménez-Sánchez, Danish Memon, Stephane Pourpe, et al.
The Journal of Infectious Diseases|July 14, 2026
Randomized, Double-Blind, Placebo-Controlled First-in-Human Trial of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem HelixFrancesco Borriello, Gavin C K W Koh, Iñaki F Troconiz, et al.
Kidney International Reports|April 29, 2021
The Role of Glomerular Epithelial Injury in Kidney Function Decline in Patients With Diabetic Kidney Disease in the TRIDENT CohortMatthew B Palmer, Amin Abedini, Casey Jackson, et al.
Gynecologic Oncology|November 25, 2018
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockadeJulia L Boland, Qin Zhou, Madhuri Martin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2014
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of AmericaGregory M Lucas, Michael J Ross, Peter G Stock, et al.
Plos Medicine|May 30, 2017
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysisAlexandra Snyder, Tavi Nathanson, Samuel A Funt, et al.
The New England Journal of Medicine|November 20, 2014
Genetic basis for clinical response to CTLA-4 blockade in melanomaAlexandra Snyder, Vladimir Makarov, Taha Merghoub, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2018
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial CancersMin Yuen Teo, Kenneth Seier, Irina Ostrovnaya, et al.
AIDS (London, England)|June 23, 2023
Association of marijuana, tobacco and alcohol use with estimated glomerular filtration rate in women living with HIV and women without HIVMolly C Fisher, Donald R Hoover, Qiuhu Shi, et al.
Pageof 12